Literature DB >> 9077528

Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

S Shiozawa1, K Shimizu, K Tanaka, K Hino.   

Abstract

Features characteristic to rheumatoid joint destruction, including synovial overgrowth and bone resorption, are experimentally produced by augmenting c-fos gene expression. We tested here if arthritic joint destruction was inhibited upon inactivation of the c-fos/AP-1 signal by administering short double-stranded AP-1 DNA oligonucleotides into mice with collagen-induced arthritis to compete for the binding of AP-1 in vivo at the promoter binding site. Arthritic joint destruction was inhibited in a sequence-specific and dose-dependent manner by oligonucleotides containing the AP-1 sequence. The oligonucleotides inhibited gene expression at the transcriptional level. Nucleotide sequences besides AP-1 also appeared to be important structurally for binding of AP-1 onto DNA and for the stability of oligonucleotides against nucleases. Immunohistochemical chase experiment administering biotinylated oligonucleotides into arthritic mice showed that AP-1 oligonucleotides reached the inflamed joint. Thus, activation of c-fos/AP-1 appears essentially important in arthritic joint destruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077528      PMCID: PMC507934          DOI: 10.1172/JCI119277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Cloning and sequencing of a cDNA encoding mouse stromelysin 1.

Authors:  K Hammani; P Henriet; Y Eeckhout
Journal:  Gene       Date:  1992-10-21       Impact factor: 3.688

Review 2.  Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis.

Authors:  S Shiozawa; T Tokuhisa
Journal:  Semin Arthritis Rheum       Date:  1992-02       Impact factor: 5.532

3.  Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice.

Authors:  S Shiozawa; Y Tanaka; T Fujita; T Tokuhisa
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

4.  Systemic gene expression after intravenous DNA delivery into adult mice.

Authors:  N Zhu; D Liggitt; Y Liu; R Debs
Journal:  Science       Date:  1993-07-09       Impact factor: 47.728

5.  The contribution of human c-fos DNA to cultured synovial cells: a transfection study.

Authors:  Y Kuroki; S Shiozawa; R Yoshihara; H Hotta
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

6.  The nonradioactive chloramphenicol acetyltransferase-enzyme-linked immunosorbent assay test is suited for promoter activity studies in plant protoplasts.

Authors:  P Porsch; S Merkelbach; J Gehlen; M Fladung
Journal:  Anal Biochem       Date:  1993-05-15       Impact factor: 3.365

7.  Cloning and expression of the cDNA encoding mouse neutrophil gelatinase: demonstration of coordinate secondary granule protein gene expression during terminal neutrophil maturation.

Authors:  T Graubert; J Johnston; N Berliner
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

8.  Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation.

Authors:  R Yoshihara; S Shiozawa; T Fujita; K Chihara
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

Authors:  H Sato; M Kita; M Seiki
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

10.  Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts.

Authors:  A Trabandt; W K Aicher; R E Gay; V P Sukhatme; H G Fassbender; S Gay
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more
  19 in total

1.  A triple altered collagen II peptide with consecutive substitutions of TCR contacting residues inhibits collagen-induced arthritis.

Authors:  Zhong-Qiang Yao; Ru Li; Zhan-Guo Li
Journal:  Ann Rheum Dis       Date:  2007-03       Impact factor: 19.103

2.  Gene therapy in autoimmune diseases.

Authors:  C H Evans; J D Whalen; C H Evans; S C Ghivizzani; P D Robbins
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

3.  Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.

Authors:  Abdul Haseeb; Mohammad Yunus Ansari; Tariq M Haqqi
Journal:  J Orthop Res       Date:  2016-05-04       Impact factor: 3.494

4.  Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro.

Authors:  Salahuddin Ahmed; Naizhen Wang; Bilal Bin Hafeez; Vinay K Cheruvu; Tariq M Haqqi
Journal:  J Nutr       Date:  2005-09       Impact factor: 4.798

Review 5.  Gene therapy for autoimmune disorders.

Authors:  C H Evans; S C Ghivizzani; T J Oligino; P D Robbins
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

6.  c-Fos/activator protein-1 transactivates wee1 kinase at G(1)/S to inhibit premature mitosis in antigen-specific Th1 cells.

Authors:  H Kawasaki; K Komai; Z Ouyang; M Murata; M Hikasa; M Ohgiri; S Shiozawa
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

7.  Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed.

Authors:  K Shimizu; H Kawasaki; T Morisawa; M Nakamura; E Yamamoto; N Yoshikawa; M Doita; K Shiozawa; S Yonehara; K Chihara; S Shiozawa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 8.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

9.  Structure of the human histamine H1 receptor gene.

Authors:  M D De Backer; I Loonen; P Verhasselt; J M Neefs; W H Luyten
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 10.  Treatment of rheumatoid arthritis with IL-1 inhibitors.

Authors:  C Gabay; W P Arend
Journal:  Springer Semin Immunopathol       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.